Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Accumulated Expenses (2016 - 2018)

Armata Pharmaceuticals' Accumulated Expenses history spans 5 years, with the latest figure at $1.8 million for Q3 2018.

  • For Q3 2018, Accumulated Expenses rose 52.93% year-over-year to $1.8 million; the TTM value through Sep 2018 reached $1.8 million, up 52.93%, while the annual FY2017 figure was $1.0 million, 17.32% up from the prior year.
  • Accumulated Expenses for Q3 2018 was $1.8 million at Armata Pharmaceuticals, up from $1.4 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $1.8 million in Q3 2018 and bottomed at $10000.0 in Q3 2016.
  • The 5-year median for Accumulated Expenses is $687500.0 (2015), against an average of $718750.0.
  • The largest annual shift saw Accumulated Expenses crashed 97.96% in 2016 before it soared 11350.0% in 2017.
  • A 5-year view of Accumulated Expenses shows it stood at $457000.0 in 2014, then rose by 7.44% to $491000.0 in 2015, then skyrocketed by 82.28% to $895000.0 in 2016, then rose by 17.32% to $1.0 million in 2017, then soared by 66.76% to $1.8 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Accumulated Expenses are $1.8 million (Q3 2018), $1.4 million (Q2 2018), and $965000.0 (Q1 2018).